Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNAs (miRNAs) such as MicroRNA 548z (MIR548Z) are short (20–24 nucleotides) non-coding RNAs that regulate gene expression at the post-transcriptional level in multicellular organisms. They are initially transcribed as longer primary transcripts (pri-miRNAs), which are processed and matured before being incorporated into the RNA-induced silencing complex (RISC). This complex mediates gene silencing by mRNA destabilization or translational inhibition through imperfect base pairing with target mRNAs. The MIR548 family, to which MIR548Z belongs, is large and primate-specific, with many members showing sequence diversity and functional heterogeneity. While some microRNA-548 family members affect cancer invasion and metastasis, definitive functions for MIR548Z specifically have not been described in the literature to date[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 548z (MIR548Z).